# Ophthalmic and Topical Dosage Form New Animal Drugs; Ivermectin Suspension
> **Food and Drug Administration** · Final rule. · Published 2001-01-24 · Effective 2001-01-24 · 66 FR 7577
## Document
- **Document number:** 01-1869
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 66 FR 7577
- **CFR reference:** 21 CFR 510
- **Publication date:** 2001-01-24
- **Effective date:** 2001-01-24
## Abstract

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a new animal drug application (NADA) filed by Blue Ridge Pharmaceuticals, Inc. The NADA provides for veterinary prescription use of ivermectin otic suspension for the treatment of adult ear mite infestations in cats and kittens.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2001/01/24/01-1869/ophthalmic-and-topical-dosage-form-new-animal-drugs-ivermectin-suspension)
---
*AI Analytics · CC0 1.0*